Global Drug Eluting Stents (DES) Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Drug Eluting Stents (DES) market report explains the definition, types, applications, major countries, and major players of the Drug Eluting Stents (DES) market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Boston Scientific

    • Reva Medical

    • Orbusneich

    • Essen

    • BBraun Melsengen AG

    • Advantec Vascular

    • Biotronik

    • Abbott Vascular

    • Promed Medical

    • Biosensors

    • Medtronic Vascular

    • Sino Medical

    • Relisys Medical

    • MicroPort Medical

    • MIV Therapeutics

    • Sahajanand

    • Blue Medical

    • Terumo Medical

    • DISA Vascular

    • Sorin

    By Type:

    • Cobalt-chromium alloy Stents

    • Magnesium alloy Stents

    • Tyrosine polycarbonate Stents

    • Nitinol Stents

    • Platinum chromium alloy Stents

    • Stainless steel Stents

    • Other Materials

    By End-User:

    • Coronary Heart Disease

    • Clinical

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Drug Eluting Stents (DES) Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Drug Eluting Stents (DES) Outlook to 2028- Original Forecasts

    • 2.2 Drug Eluting Stents (DES) Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Drug Eluting Stents (DES) Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Drug Eluting Stents (DES) Market- Recent Developments

    • 6.1 Drug Eluting Stents (DES) Market News and Developments

    • 6.2 Drug Eluting Stents (DES) Market Deals Landscape

    7 Drug Eluting Stents (DES) Raw Materials and Cost Structure Analysis

    • 7.1 Drug Eluting Stents (DES) Key Raw Materials

    • 7.2 Drug Eluting Stents (DES) Price Trend of Key Raw Materials

    • 7.3 Drug Eluting Stents (DES) Key Suppliers of Raw Materials

    • 7.4 Drug Eluting Stents (DES) Market Concentration Rate of Raw Materials

    • 7.5 Drug Eluting Stents (DES) Cost Structure Analysis

      • 7.5.1 Drug Eluting Stents (DES) Raw Materials Analysis

      • 7.5.2 Drug Eluting Stents (DES) Labor Cost Analysis

      • 7.5.3 Drug Eluting Stents (DES) Manufacturing Expenses Analysis

    8 Global Drug Eluting Stents (DES) Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Drug Eluting Stents (DES) Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Drug Eluting Stents (DES) Export by Region (Top 10 Countries) (2017-2028)

    9 Global Drug Eluting Stents (DES) Market Outlook by Types and Applications to 2022

    • 9.1 Global Drug Eluting Stents (DES) Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Cobalt-chromium alloy Stents Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Magnesium alloy Stents Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Tyrosine polycarbonate Stents Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Nitinol Stents Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Platinum chromium alloy Stents Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Stainless steel Stents Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global Other Materials Consumption and Growth Rate (2017-2022)

    • 9.2 Global Drug Eluting Stents (DES) Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Coronary Heart Disease Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinical Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Drug Eluting Stents (DES) Market Analysis and Outlook till 2022

    • 10.1 Global Drug Eluting Stents (DES) Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Drug Eluting Stents (DES) Consumption (2017-2022)

      • 10.2.2 Canada Drug Eluting Stents (DES) Consumption (2017-2022)

      • 10.2.3 Mexico Drug Eluting Stents (DES) Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Drug Eluting Stents (DES) Consumption (2017-2022)

      • 10.3.2 UK Drug Eluting Stents (DES) Consumption (2017-2022)

      • 10.3.3 Spain Drug Eluting Stents (DES) Consumption (2017-2022)

      • 10.3.4 Belgium Drug Eluting Stents (DES) Consumption (2017-2022)

      • 10.3.5 France Drug Eluting Stents (DES) Consumption (2017-2022)

      • 10.3.6 Italy Drug Eluting Stents (DES) Consumption (2017-2022)

      • 10.3.7 Denmark Drug Eluting Stents (DES) Consumption (2017-2022)

      • 10.3.8 Finland Drug Eluting Stents (DES) Consumption (2017-2022)

      • 10.3.9 Norway Drug Eluting Stents (DES) Consumption (2017-2022)

      • 10.3.10 Sweden Drug Eluting Stents (DES) Consumption (2017-2022)

      • 10.3.11 Poland Drug Eluting Stents (DES) Consumption (2017-2022)

      • 10.3.12 Russia Drug Eluting Stents (DES) Consumption (2017-2022)

      • 10.3.13 Turkey Drug Eluting Stents (DES) Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Drug Eluting Stents (DES) Consumption (2017-2022)

      • 10.4.2 Japan Drug Eluting Stents (DES) Consumption (2017-2022)

      • 10.4.3 India Drug Eluting Stents (DES) Consumption (2017-2022)

      • 10.4.4 South Korea Drug Eluting Stents (DES) Consumption (2017-2022)

      • 10.4.5 Pakistan Drug Eluting Stents (DES) Consumption (2017-2022)

      • 10.4.6 Bangladesh Drug Eluting Stents (DES) Consumption (2017-2022)

      • 10.4.7 Indonesia Drug Eluting Stents (DES) Consumption (2017-2022)

      • 10.4.8 Thailand Drug Eluting Stents (DES) Consumption (2017-2022)

      • 10.4.9 Singapore Drug Eluting Stents (DES) Consumption (2017-2022)

      • 10.4.10 Malaysia Drug Eluting Stents (DES) Consumption (2017-2022)

      • 10.4.11 Philippines Drug Eluting Stents (DES) Consumption (2017-2022)

      • 10.4.12 Vietnam Drug Eluting Stents (DES) Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Drug Eluting Stents (DES) Consumption (2017-2022)

      • 10.5.2 Colombia Drug Eluting Stents (DES) Consumption (2017-2022)

      • 10.5.3 Chile Drug Eluting Stents (DES) Consumption (2017-2022)

      • 10.5.4 Argentina Drug Eluting Stents (DES) Consumption (2017-2022)

      • 10.5.5 Venezuela Drug Eluting Stents (DES) Consumption (2017-2022)

      • 10.5.6 Peru Drug Eluting Stents (DES) Consumption (2017-2022)

      • 10.5.7 Puerto Rico Drug Eluting Stents (DES) Consumption (2017-2022)

      • 10.5.8 Ecuador Drug Eluting Stents (DES) Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Drug Eluting Stents (DES) Consumption (2017-2022)

      • 10.6.2 Kuwait Drug Eluting Stents (DES) Consumption (2017-2022)

      • 10.6.3 Oman Drug Eluting Stents (DES) Consumption (2017-2022)

      • 10.6.4 Qatar Drug Eluting Stents (DES) Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Drug Eluting Stents (DES) Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Drug Eluting Stents (DES) Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Drug Eluting Stents (DES) Consumption (2017-2022)

      • 10.7.2 South Africa Drug Eluting Stents (DES) Consumption (2017-2022)

      • 10.7.3 Egypt Drug Eluting Stents (DES) Consumption (2017-2022)

      • 10.7.4 Algeria Drug Eluting Stents (DES) Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Drug Eluting Stents (DES) Consumption (2017-2022)

      • 10.8.2 New Zealand Drug Eluting Stents (DES) Consumption (2017-2022)

    11 Global Drug Eluting Stents (DES) Competitive Analysis

    • 11.1 Boston Scientific

      • 11.1.1 Boston Scientific Company Details

      • 11.1.2 Boston Scientific Drug Eluting Stents (DES) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Boston Scientific Drug Eluting Stents (DES) Main Business and Markets Served

      • 11.1.4 Boston Scientific Drug Eluting Stents (DES) Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Reva Medical

      • 11.2.1 Reva Medical Company Details

      • 11.2.2 Reva Medical Drug Eluting Stents (DES) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Reva Medical Drug Eluting Stents (DES) Main Business and Markets Served

      • 11.2.4 Reva Medical Drug Eluting Stents (DES) Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Orbusneich

      • 11.3.1 Orbusneich Company Details

      • 11.3.2 Orbusneich Drug Eluting Stents (DES) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Orbusneich Drug Eluting Stents (DES) Main Business and Markets Served

      • 11.3.4 Orbusneich Drug Eluting Stents (DES) Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Essen

      • 11.4.1 Essen Company Details

      • 11.4.2 Essen Drug Eluting Stents (DES) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Essen Drug Eluting Stents (DES) Main Business and Markets Served

      • 11.4.4 Essen Drug Eluting Stents (DES) Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 BBraun Melsengen AG

      • 11.5.1 BBraun Melsengen AG Company Details

      • 11.5.2 BBraun Melsengen AG Drug Eluting Stents (DES) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 BBraun Melsengen AG Drug Eluting Stents (DES) Main Business and Markets Served

      • 11.5.4 BBraun Melsengen AG Drug Eluting Stents (DES) Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Advantec Vascular

      • 11.6.1 Advantec Vascular Company Details

      • 11.6.2 Advantec Vascular Drug Eluting Stents (DES) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Advantec Vascular Drug Eluting Stents (DES) Main Business and Markets Served

      • 11.6.4 Advantec Vascular Drug Eluting Stents (DES) Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Biotronik

      • 11.7.1 Biotronik Company Details

      • 11.7.2 Biotronik Drug Eluting Stents (DES) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Biotronik Drug Eluting Stents (DES) Main Business and Markets Served

      • 11.7.4 Biotronik Drug Eluting Stents (DES) Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Abbott Vascular

      • 11.8.1 Abbott Vascular Company Details

      • 11.8.2 Abbott Vascular Drug Eluting Stents (DES) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Abbott Vascular Drug Eluting Stents (DES) Main Business and Markets Served

      • 11.8.4 Abbott Vascular Drug Eluting Stents (DES) Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Promed Medical

      • 11.9.1 Promed Medical Company Details

      • 11.9.2 Promed Medical Drug Eluting Stents (DES) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Promed Medical Drug Eluting Stents (DES) Main Business and Markets Served

      • 11.9.4 Promed Medical Drug Eluting Stents (DES) Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Biosensors

      • 11.10.1 Biosensors Company Details

      • 11.10.2 Biosensors Drug Eluting Stents (DES) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Biosensors Drug Eluting Stents (DES) Main Business and Markets Served

      • 11.10.4 Biosensors Drug Eluting Stents (DES) Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 Medtronic Vascular

      • 11.11.1 Medtronic Vascular Company Details

      • 11.11.2 Medtronic Vascular Drug Eluting Stents (DES) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 Medtronic Vascular Drug Eluting Stents (DES) Main Business and Markets Served

      • 11.11.4 Medtronic Vascular Drug Eluting Stents (DES) Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 Sino Medical

      • 11.12.1 Sino Medical Company Details

      • 11.12.2 Sino Medical Drug Eluting Stents (DES) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 Sino Medical Drug Eluting Stents (DES) Main Business and Markets Served

      • 11.12.4 Sino Medical Drug Eluting Stents (DES) Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    • 11.13 Relisys Medical

      • 11.13.1 Relisys Medical Company Details

      • 11.13.2 Relisys Medical Drug Eluting Stents (DES) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.13.3 Relisys Medical Drug Eluting Stents (DES) Main Business and Markets Served

      • 11.13.4 Relisys Medical Drug Eluting Stents (DES) Product Portfolio

      • 11.13.5 Recent Research and Development Strategies

    • 11.14 MicroPort Medical

      • 11.14.1 MicroPort Medical Company Details

      • 11.14.2 MicroPort Medical Drug Eluting Stents (DES) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.14.3 MicroPort Medical Drug Eluting Stents (DES) Main Business and Markets Served

      • 11.14.4 MicroPort Medical Drug Eluting Stents (DES) Product Portfolio

      • 11.14.5 Recent Research and Development Strategies

    • 11.15 MIV Therapeutics

      • 11.15.1 MIV Therapeutics Company Details

      • 11.15.2 MIV Therapeutics Drug Eluting Stents (DES) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.15.3 MIV Therapeutics Drug Eluting Stents (DES) Main Business and Markets Served

      • 11.15.4 MIV Therapeutics Drug Eluting Stents (DES) Product Portfolio

      • 11.15.5 Recent Research and Development Strategies

    • 11.16 Sahajanand

      • 11.16.1 Sahajanand Company Details

      • 11.16.2 Sahajanand Drug Eluting Stents (DES) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.16.3 Sahajanand Drug Eluting Stents (DES) Main Business and Markets Served

      • 11.16.4 Sahajanand Drug Eluting Stents (DES) Product Portfolio

      • 11.16.5 Recent Research and Development Strategies

    • 11.17 Blue Medical

      • 11.17.1 Blue Medical Company Details

      • 11.17.2 Blue Medical Drug Eluting Stents (DES) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.17.3 Blue Medical Drug Eluting Stents (DES) Main Business and Markets Served

      • 11.17.4 Blue Medical Drug Eluting Stents (DES) Product Portfolio

      • 11.17.5 Recent Research and Development Strategies

    • 11.18 Terumo Medical

      • 11.18.1 Terumo Medical Company Details

      • 11.18.2 Terumo Medical Drug Eluting Stents (DES) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.18.3 Terumo Medical Drug Eluting Stents (DES) Main Business and Markets Served

      • 11.18.4 Terumo Medical Drug Eluting Stents (DES) Product Portfolio

      • 11.18.5 Recent Research and Development Strategies

    • 11.19 DISA Vascular

      • 11.19.1 DISA Vascular Company Details

      • 11.19.2 DISA Vascular Drug Eluting Stents (DES) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.19.3 DISA Vascular Drug Eluting Stents (DES) Main Business and Markets Served

      • 11.19.4 DISA Vascular Drug Eluting Stents (DES) Product Portfolio

      • 11.19.5 Recent Research and Development Strategies

    • 11.20 Sorin

      • 11.20.1 Sorin Company Details

      • 11.20.2 Sorin Drug Eluting Stents (DES) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.20.3 Sorin Drug Eluting Stents (DES) Main Business and Markets Served

      • 11.20.4 Sorin Drug Eluting Stents (DES) Product Portfolio

      • 11.20.5 Recent Research and Development Strategies

    12 Global Drug Eluting Stents (DES) Market Outlook by Types and Applications to 2028

    • 12.1 Global Drug Eluting Stents (DES) Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Cobalt-chromium alloy Stents Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Magnesium alloy Stents Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Tyrosine polycarbonate Stents Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Nitinol Stents Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.5 Global Platinum chromium alloy Stents Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.6 Global Stainless steel Stents Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.7 Global Other Materials Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Drug Eluting Stents (DES) Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Coronary Heart Disease Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Clinical Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Drug Eluting Stents (DES) Market Analysis and Outlook to 2028

    • 13.1 Global Drug Eluting Stents (DES) Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Drug Eluting Stents (DES) Consumption Forecast (2022-2028)

      • 13.2.2 Canada Drug Eluting Stents (DES) Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Drug Eluting Stents (DES) Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Drug Eluting Stents (DES) Consumption Forecast (2022-2028)

      • 13.3.2 UK Drug Eluting Stents (DES) Consumption Forecast (2022-2028)

      • 13.3.3 Spain Drug Eluting Stents (DES) Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Drug Eluting Stents (DES) Consumption Forecast (2022-2028)

      • 13.3.5 France Drug Eluting Stents (DES) Consumption Forecast (2022-2028)

      • 13.3.6 Italy Drug Eluting Stents (DES) Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Drug Eluting Stents (DES) Consumption Forecast (2022-2028)

      • 13.3.8 Finland Drug Eluting Stents (DES) Consumption Forecast (2022-2028)

      • 13.3.9 Norway Drug Eluting Stents (DES) Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Drug Eluting Stents (DES) Consumption Forecast (2022-2028)

      • 13.3.11 Poland Drug Eluting Stents (DES) Consumption Forecast (2022-2028)

      • 13.3.12 Russia Drug Eluting Stents (DES) Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Drug Eluting Stents (DES) Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Drug Eluting Stents (DES) Consumption Forecast (2022-2028)

      • 13.4.2 Japan Drug Eluting Stents (DES) Consumption Forecast (2022-2028)

      • 13.4.3 India Drug Eluting Stents (DES) Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Drug Eluting Stents (DES) Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Drug Eluting Stents (DES) Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Drug Eluting Stents (DES) Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Drug Eluting Stents (DES) Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Drug Eluting Stents (DES) Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Drug Eluting Stents (DES) Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Drug Eluting Stents (DES) Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Drug Eluting Stents (DES) Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Drug Eluting Stents (DES) Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Drug Eluting Stents (DES) Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Drug Eluting Stents (DES) Consumption Forecast (2022-2028)

      • 13.5.3 Chile Drug Eluting Stents (DES) Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Drug Eluting Stents (DES) Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Drug Eluting Stents (DES) Consumption Forecast (2022-2028)

      • 13.5.6 Peru Drug Eluting Stents (DES) Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Drug Eluting Stents (DES) Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Drug Eluting Stents (DES) Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Drug Eluting Stents (DES) Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Drug Eluting Stents (DES) Consumption Forecast (2022-2028)

      • 13.6.3 Oman Drug Eluting Stents (DES) Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Drug Eluting Stents (DES) Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Drug Eluting Stents (DES) Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Drug Eluting Stents (DES) Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Drug Eluting Stents (DES) Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Drug Eluting Stents (DES) Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Drug Eluting Stents (DES) Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Drug Eluting Stents (DES) Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Drug Eluting Stents (DES) Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Drug Eluting Stents (DES) Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Drug Eluting Stents (DES)

    • Figure of Drug Eluting Stents (DES) Picture

    • Table Global Drug Eluting Stents (DES) Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Drug Eluting Stents (DES) Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Cobalt-chromium alloy Stents Consumption and Growth Rate (2017-2022)

    • Figure Global Magnesium alloy Stents Consumption and Growth Rate (2017-2022)

    • Figure Global Tyrosine polycarbonate Stents Consumption and Growth Rate (2017-2022)

    • Figure Global Nitinol Stents Consumption and Growth Rate (2017-2022)

    • Figure Global Platinum chromium alloy Stents Consumption and Growth Rate (2017-2022)

    • Figure Global Stainless steel Stents Consumption and Growth Rate (2017-2022)

    • Figure Global Other Materials Consumption and Growth Rate (2017-2022)

    • Figure Global Coronary Heart Disease Consumption and Growth Rate (2017-2022)

    • Figure Global Clinical Consumption and Growth Rate (2017-2022)

    • Figure Global Drug Eluting Stents (DES) Consumption by Country (2017-2022)

    • Table North America Drug Eluting Stents (DES) Consumption by Country (2017-2022)

    • Figure United States Drug Eluting Stents (DES) Consumption and Growth Rate (2017-2022)

    • Figure Canada Drug Eluting Stents (DES) Consumption and Growth Rate (2017-2022)

    • Figure Mexico Drug Eluting Stents (DES) Consumption and Growth Rate (2017-2022)

    • Table Europe Drug Eluting Stents (DES) Consumption by Country (2017-2022)

    • Figure Germany Drug Eluting Stents (DES) Consumption and Growth Rate (2017-2022)

    • Figure UK Drug Eluting Stents (DES) Consumption and Growth Rate (2017-2022)

    • Figure Spain Drug Eluting Stents (DES) Consumption and Growth Rate (2017-2022)

    • Figure Belgium Drug Eluting Stents (DES) Consumption and Growth Rate (2017-2022)

    • Figure France Drug Eluting Stents (DES) Consumption and Growth Rate (2017-2022)

    • Figure Italy Drug Eluting Stents (DES) Consumption and Growth Rate (2017-2022)

    • Figure Denmark Drug Eluting Stents (DES) Consumption and Growth Rate (2017-2022)

    • Figure Finland Drug Eluting Stents (DES) Consumption and Growth Rate (2017-2022)

    • Figure Norway Drug Eluting Stents (DES) Consumption and Growth Rate (2017-2022)

    • Figure Sweden Drug Eluting Stents (DES) Consumption and Growth Rate (2017-2022)

    • Figure Poland Drug Eluting Stents (DES) Consumption and Growth Rate (2017-2022)

    • Figure Russia Drug Eluting Stents (DES) Consumption and Growth Rate (2017-2022)

    • Figure Turkey Drug Eluting Stents (DES) Consumption and Growth Rate (2017-2022)

    • Table APAC Drug Eluting Stents (DES) Consumption by Country (2017-2022)

    • Figure China Drug Eluting Stents (DES) Consumption and Growth Rate (2017-2022)

    • Figure Japan Drug Eluting Stents (DES) Consumption and Growth Rate (2017-2022)

    • Figure India Drug Eluting Stents (DES) Consumption and Growth Rate (2017-2022)

    • Figure South Korea Drug Eluting Stents (DES) Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Drug Eluting Stents (DES) Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Drug Eluting Stents (DES) Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Drug Eluting Stents (DES) Consumption and Growth Rate (2017-2022)

    • Figure Thailand Drug Eluting Stents (DES) Consumption and Growth Rate (2017-2022)

    • Figure Singapore Drug Eluting Stents (DES) Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Drug Eluting Stents (DES) Consumption and Growth Rate (2017-2022)

    • Figure Philippines Drug Eluting Stents (DES) Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Drug Eluting Stents (DES) Consumption and Growth Rate (2017-2022)

    • Table South America Drug Eluting Stents (DES) Consumption by Country (2017-2022)

    • Figure Brazil Drug Eluting Stents (DES) Consumption and Growth Rate (2017-2022)

    • Figure Colombia Drug Eluting Stents (DES) Consumption and Growth Rate (2017-2022)

    • Figure Chile Drug Eluting Stents (DES) Consumption and Growth Rate (2017-2022)

    • Figure Argentina Drug Eluting Stents (DES) Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Drug Eluting Stents (DES) Consumption and Growth Rate (2017-2022)

    • Figure Peru Drug Eluting Stents (DES) Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Drug Eluting Stents (DES) Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Drug Eluting Stents (DES) Consumption and Growth Rate (2017-2022)

    • Table GCC Drug Eluting Stents (DES) Consumption by Country (2017-2022)

    • Figure Bahrain Drug Eluting Stents (DES) Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Drug Eluting Stents (DES) Consumption and Growth Rate (2017-2022)

    • Figure Oman Drug Eluting Stents (DES) Consumption and Growth Rate (2017-2022)

    • Figure Qatar Drug Eluting Stents (DES) Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Drug Eluting Stents (DES) Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Drug Eluting Stents (DES) Consumption and Growth Rate (2017-2022)

    • Table Africa Drug Eluting Stents (DES) Consumption by Country (2017-2022)

    • Figure Nigeria Drug Eluting Stents (DES) Consumption and Growth Rate (2017-2022)

    • Figure South Africa Drug Eluting Stents (DES) Consumption and Growth Rate (2017-2022)

    • Figure Egypt Drug Eluting Stents (DES) Consumption and Growth Rate (2017-2022)

    • Figure Algeria Drug Eluting Stents (DES) Consumption and Growth Rate (2017-2022)

    • Table Oceania Drug Eluting Stents (DES) Consumption by Country (2017-2022)

    • Figure Australia Drug Eluting Stents (DES) Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Drug Eluting Stents (DES) Consumption and Growth Rate (2017-2022)

    • Table Boston Scientific Company Details

    • Table Boston Scientific Drug Eluting Stents (DES) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boston Scientific Drug Eluting Stents (DES) Main Business and Markets Served

    • Table Boston Scientific Drug Eluting Stents (DES) Product Portfolio

    • Table Reva Medical Company Details

    • Table Reva Medical Drug Eluting Stents (DES) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Reva Medical Drug Eluting Stents (DES) Main Business and Markets Served

    • Table Reva Medical Drug Eluting Stents (DES) Product Portfolio

    • Table Orbusneich Company Details

    • Table Orbusneich Drug Eluting Stents (DES) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Orbusneich Drug Eluting Stents (DES) Main Business and Markets Served

    • Table Orbusneich Drug Eluting Stents (DES) Product Portfolio

    • Table Essen Company Details

    • Table Essen Drug Eluting Stents (DES) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Essen Drug Eluting Stents (DES) Main Business and Markets Served

    • Table Essen Drug Eluting Stents (DES) Product Portfolio

    • Table BBraun Melsengen AG Company Details

    • Table BBraun Melsengen AG Drug Eluting Stents (DES) Sales, Price, Value and Gross Profit (2017-2022)

    • Table BBraun Melsengen AG Drug Eluting Stents (DES) Main Business and Markets Served

    • Table BBraun Melsengen AG Drug Eluting Stents (DES) Product Portfolio

    • Table Advantec Vascular Company Details

    • Table Advantec Vascular Drug Eluting Stents (DES) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Advantec Vascular Drug Eluting Stents (DES) Main Business and Markets Served

    • Table Advantec Vascular Drug Eluting Stents (DES) Product Portfolio

    • Table Biotronik Company Details

    • Table Biotronik Drug Eluting Stents (DES) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biotronik Drug Eluting Stents (DES) Main Business and Markets Served

    • Table Biotronik Drug Eluting Stents (DES) Product Portfolio

    • Table Abbott Vascular Company Details

    • Table Abbott Vascular Drug Eluting Stents (DES) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Vascular Drug Eluting Stents (DES) Main Business and Markets Served

    • Table Abbott Vascular Drug Eluting Stents (DES) Product Portfolio

    • Table Promed Medical Company Details

    • Table Promed Medical Drug Eluting Stents (DES) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Promed Medical Drug Eluting Stents (DES) Main Business and Markets Served

    • Table Promed Medical Drug Eluting Stents (DES) Product Portfolio

    • Table Biosensors Company Details

    • Table Biosensors Drug Eluting Stents (DES) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biosensors Drug Eluting Stents (DES) Main Business and Markets Served

    • Table Biosensors Drug Eluting Stents (DES) Product Portfolio

    • Table Medtronic Vascular Company Details

    • Table Medtronic Vascular Drug Eluting Stents (DES) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Medtronic Vascular Drug Eluting Stents (DES) Main Business and Markets Served

    • Table Medtronic Vascular Drug Eluting Stents (DES) Product Portfolio

    • Table Sino Medical Company Details

    • Table Sino Medical Drug Eluting Stents (DES) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sino Medical Drug Eluting Stents (DES) Main Business and Markets Served

    • Table Sino Medical Drug Eluting Stents (DES) Product Portfolio

    • Table Relisys Medical Company Details

    • Table Relisys Medical Drug Eluting Stents (DES) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Relisys Medical Drug Eluting Stents (DES) Main Business and Markets Served

    • Table Relisys Medical Drug Eluting Stents (DES) Product Portfolio

    • Table MicroPort Medical Company Details

    • Table MicroPort Medical Drug Eluting Stents (DES) Sales, Price, Value and Gross Profit (2017-2022)

    • Table MicroPort Medical Drug Eluting Stents (DES) Main Business and Markets Served

    • Table MicroPort Medical Drug Eluting Stents (DES) Product Portfolio

    • Table MIV Therapeutics Company Details

    • Table MIV Therapeutics Drug Eluting Stents (DES) Sales, Price, Value and Gross Profit (2017-2022)

    • Table MIV Therapeutics Drug Eluting Stents (DES) Main Business and Markets Served

    • Table MIV Therapeutics Drug Eluting Stents (DES) Product Portfolio

    • Table Sahajanand Company Details

    • Table Sahajanand Drug Eluting Stents (DES) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sahajanand Drug Eluting Stents (DES) Main Business and Markets Served

    • Table Sahajanand Drug Eluting Stents (DES) Product Portfolio

    • Table Blue Medical Company Details

    • Table Blue Medical Drug Eluting Stents (DES) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Blue Medical Drug Eluting Stents (DES) Main Business and Markets Served

    • Table Blue Medical Drug Eluting Stents (DES) Product Portfolio

    • Table Terumo Medical Company Details

    • Table Terumo Medical Drug Eluting Stents (DES) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Terumo Medical Drug Eluting Stents (DES) Main Business and Markets Served

    • Table Terumo Medical Drug Eluting Stents (DES) Product Portfolio

    • Table DISA Vascular Company Details

    • Table DISA Vascular Drug Eluting Stents (DES) Sales, Price, Value and Gross Profit (2017-2022)

    • Table DISA Vascular Drug Eluting Stents (DES) Main Business and Markets Served

    • Table DISA Vascular Drug Eluting Stents (DES) Product Portfolio

    • Table Sorin Company Details

    • Table Sorin Drug Eluting Stents (DES) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sorin Drug Eluting Stents (DES) Main Business and Markets Served

    • Table Sorin Drug Eluting Stents (DES) Product Portfolio

    • Figure Global Cobalt-chromium alloy Stents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Magnesium alloy Stents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Tyrosine polycarbonate Stents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Nitinol Stents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Platinum chromium alloy Stents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Stainless steel Stents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Materials Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Coronary Heart Disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Drug Eluting Stents (DES) Consumption Forecast by Country (2022-2028)

    • Table North America Drug Eluting Stents (DES) Consumption Forecast by Country (2022-2028)

    • Figure United States Drug Eluting Stents (DES) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Drug Eluting Stents (DES) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Drug Eluting Stents (DES) Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Drug Eluting Stents (DES) Consumption Forecast by Country (2022-2028)

    • Figure Germany Drug Eluting Stents (DES) Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Drug Eluting Stents (DES) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Drug Eluting Stents (DES) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Drug Eluting Stents (DES) Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Drug Eluting Stents (DES) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Drug Eluting Stents (DES) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Drug Eluting Stents (DES) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Drug Eluting Stents (DES) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Drug Eluting Stents (DES) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Drug Eluting Stents (DES) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Drug Eluting Stents (DES) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Drug Eluting Stents (DES) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Drug Eluting Stents (DES) Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Drug Eluting Stents (DES) Consumption Forecast by Country (2022-2028)

    • Figure China Drug Eluting Stents (DES) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Drug Eluting Stents (DES) Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Drug Eluting Stents (DES) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Drug Eluting Stents (DES) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Drug Eluting Stents (DES) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Drug Eluting Stents (DES) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Drug Eluting Stents (DES) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Drug Eluting Stents (DES) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Drug Eluting Stents (DES) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Drug Eluting Stents (DES) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Drug Eluting Stents (DES) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Drug Eluting Stents (DES) Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Drug Eluting Stents (DES) Consumption Forecast by Country (2022-2028)

    • Figure Brazil Drug Eluting Stents (DES) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Drug Eluting Stents (DES) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Drug Eluting Stents (DES) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Drug Eluting Stents (DES) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Drug Eluting Stents (DES) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Drug Eluting Stents (DES) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Drug Eluting Stents (DES) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Drug Eluting Stents (DES) Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Drug Eluting Stents (DES) Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Drug Eluting Stents (DES) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Drug Eluting Stents (DES) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Drug Eluting Stents (DES) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Drug Eluting Stents (DES) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Drug Eluting Stents (DES) Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Drug Eluting Stents (DES) Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Drug Eluting Stents (DES) Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Drug Eluting Stents (DES) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Drug Eluting Stents (DES) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Drug Eluting Stents (DES) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Drug Eluting Stents (DES) Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Drug Eluting Stents (DES) Consumption Forecast by Country (2022-2028)

    • Figure Australia Drug Eluting Stents (DES) Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Drug Eluting Stents (DES) Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.